Testing a Barbershop-based HIV Prevention Initiative Among Men (TRIM)

April 4, 2024 updated by: HIV Prevention Trials Network

Feasibility and Acceptability of a Barbershop Based HIV Prevention Initiative Among Heterosexual Men in Kalangala Islands, Uganda: A Cluster Randomized Trial

To test community-based approaches to engage heterosexual men at risk for HIV and specifically to assess the feasibility and acceptability of a barbershop based HIV prevention program.

Study Overview

Detailed Description

HPTN 111/TRIM is a cluster randomized study to assess the feasibility and acceptability of a barbershop-based HIV prevention program. Eighteen barbershops in Kalangala District, Uganda will be purposively selected to participate in the study and randomized 2:1 to provide the barbershop-based HIV prevention initiative (intervention) or the standard-of-care (control). Individual participants will be enrolled from the barbershops and receive intervention or control services based on their barbershop. The barbershop-based HIV prevention initiative will include barber provided status-neutral HIV education, HIV self-test kits, and information about where to receive HIV prevention services.

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Kampala, Uganda
        • MU-JHU Research Collaboration (MUJHU CARE LTD) CRS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Persons who identify as a heterosexual male and meet all of the following criteria are eligible for inclusion in this study:

  1. Age ≥ 16 years

    a. Any participants 16-17 years old will be enrolled following the Uganda National Council for Science and Technology (UNCST) guidelines for mature and emancipated minors

  2. Able and willing to provide informed consent
  3. Behaviorally vulnerable to HIV, based on self-report of at least one of the following in the last three months:

    1. Had condomless sex with a person of unknown HIV status or a person living with HIV
    2. Had more than one sexual partner
  4. HIV negative per Ugandan Ministry of Health guidelines and the Study-specific Procedures (SSP) Manual
  5. Is a regular customer at a participating barbershop as defined in the SSP Manual

Exclusion Criteria:

Persons who meet any of the following criteria will be excluded from this study:

  1. Not planning to stay in the study catchment area in the next 12 months
  2. Any other condition that in the opinion of the Investigator of Record (IoR)/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Participants who report sex with other men will not be excluded from this study so long as they meet the inclusion and exclusion criteria listed above.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Barbershops Group
Participants recruited from intervention barbershops will receive the barbershop-based HIV prevention initiative. The trained barber will provide the following services during regular haircut services: general, status-neutral HIV education, HIV self-test kits, and information about where to receive HIV prevention services. The barber will also lead peer support group education every two months for clients enrolled in the study.
General, status-neutral HIV education
HIV self-test kits
Information about where to receive HIV prevention services
Barber-led peer support group education
Active Comparator: Control Barbershops Group
Participants recruited from control barbershops will receive standard-of-care HIV prevention services which include facility-based HIV risk reduction counseling and testing and providing information about facility distributed HIV self-test kits.
Facility-based HIV risk reduction counseling
Facility-based HIV testing
Information about facility distributed HIV self-test kits
STI testing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 26 and Week 52
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Participant responses from surveys at Week 26 and Week 52 about acceptability of the intervention
Week 26 and Week 52
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 13, Week 26, Week 39, Week 52, Week 65
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Barber responses from surveys about feasibility and acceptability of intervention
Week 13, Week 26, Week 39, Week 52, Week 65
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 26 and Week 52
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Recruitment rates during enrollment and retention in study and barbershop activities at Week 26 and Week 52
Week 26 and Week 52
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 13, Week 26, Week 39, Week 52, Week 65
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Frequency of barber-participant interactions
Week 13, Week 26, Week 39, Week 52, Week 65
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 13, Week 26, Week 39, Week 52, Week 65
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Proportion of barber-participant interactions that include delivery of the intervention
Week 13, Week 26, Week 39, Week 52, Week 65

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare completion of self-initiated HIV testing between intervention and control groups
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Self-report of HIV test conducted between enrollment and study visit at Week 26, and between the Week 26 and Week 52 study visits
Week 26 and Week 52
To evaluate the preliminary effectiveness of the intervention on change in risk behaviors associated with HIV acquisition
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported risk behaviors at Week 26 and Week 52, including condom use
Week 26 and Week 52
To evaluate the preliminary effectiveness of the intervention on change in risk behaviors associated with HIV acquisition
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported risk behaviors at Week 26 and Week 52, including number of total sexual partners
Week 26 and Week 52
To evaluate the preliminary effectiveness of the intervention on change in risk behaviors associated with HIV acquisition
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported risk behaviors at Week 26 and Week 52, including number of new sexual partners
Week 26 and Week 52
To compare interest in or use of HIV prevention services between intervention and control groups
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Voluntary medical male circumcision (VMMC) during the study
Week 26 and Week 52
To compare interest in or use of HIV prevention services between intervention and control groups
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported referral to PEP care or use of PEP
Week 26 and Week 52
To compare interest in or use of HIV prevention services between intervention and control groups
Time Frame: Week 26 and Week 52
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported referral to PrEP care or use of any PrEP method during the study
Week 26 and Week 52

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Zubair Lukyamuzi, MBChB, MPH, Makerere University, Johns Hopkins University Collaboration (MU-JHU)
  • Study Chair: Brenda Gati Mirembe, MBChB, MscEpi, Makerere University, Johns Hopkins University Collaboration (MU-JHU)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2024

Primary Completion (Estimated)

April 30, 2025

Study Completion (Estimated)

April 30, 2025

Study Registration Dates

First Submitted

October 27, 2023

First Submitted That Met QC Criteria

November 22, 2023

First Posted (Actual)

November 28, 2023

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 4, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV Infections

Clinical Trials on General, status-neutral HIV education

3
Subscribe